IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes

Conditions:   Diabetes Mellitus Type 2 in Obese;   Inflammation;   Metabolic Disease;   Glucose Metabolism Disorders (Including Diabetes Mellitus) Intervention:   Drug: Anakinra Prefilled Syringe Sponsor:   University Hospital, Basel, Switzerland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials